A Novel LMX1A Frameshift Variant Underlies Familial Phenotypic Heterogeneity in DFNA7
Human Mutation · 2026-01 · 2026 (1)
DOI: 10.1155/humu/9930672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Mutation, online erschienen am 30.05.2026. Verfasst von Chenyang Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China, lzu.edu.cn. Hauptthemen laut MEDLINE: Transcription Factors, Frameshift Mutation, LIM-Homeodomain Proteins, Hearing Loss, Sensorineural. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Gansu Province.
Abstract (Originalsprache)
Pathogenic variants in the LIM‐homeodomain transcription factor LMX1A represent a rare yet critical etiology for autosomal dominant nonsyndromic hearing loss 7 (DFNA7) and less frequently, its autosomal recessive counterpart (ARNSHL). Here, we describe a novel heterozygous frameshift variant, LMX1A c.405delT (p.Phe135LeufsTer3), identified in a three‐generation Chinese family, cosegregating with progressive and asymmetric sensorineural hearing loss (ASNHL). Clinical manifestations exhibited significant intrafamilial phenotypic variability, with hearing loss (HL) severity ranging from mild to profound, and onset varying from infancy to mid‐adulthood. High‐resolution imaging revealed bilateral cochlear aperture stenosis (CAS) in the severely affected proband. Whole‐exome sequencing (WES) and cosegregation analysis confirmed this novel variant. Structural modeling predicted the truncation of both the DNA‐binding homeodomain and the C‐terminus. Subsequent reporter assays demonstrated a significant loss of transcriptional activity. Furthermore, plasmid titration experiments and Actinomycin D chase assays functionally corroborated the haploinsufficiency mechanism and excluded the dominant‐negative effect. Integrative multiomics profiling (RNA‐seq and DIA‐based proteomics) of in vitro HEI‐OC1 model revealed molecular perturbations following Lmx1a deficiency, primarily involved in synaptic signaling and immune‐inflammatory cascades. This study broadens the LMX1A mutational landscape, refines the clinical phenotypic spectrum of DFNA7 and establishes insufficient LMX1A dosage as the primary disease driver.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China, lzu.edu.cn.
- Department of Otolaryngology-Head and Neck Surgery, Lanzhou University Second Hospital, Lanzhou, Gansu, China, ldey.cn.
- Center for Mitochondrial Biomedicine and Department of Ophthalmology, Zhejiang University School of Medicine, Zhejiang, China, zju.edu.cn.
- Department of Otolaryngology-Head and Neck Surgery, Maternal and Child Health Hospital of Gansu Province, Lanzhou, Gansu, China.
- Department of Otolaryngology-Head and Neck Surgery, Gansu Provincial Hospital, Lanzhou, Gansu, China, gsyy.cn.
ORCID-Profile: Chenyang Xu, Zhipeng Nie, Suyang Wang, Yiming Zhu, Xiaowen Liu, Yufen Guo
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Gansu Province
Zitieren
APA
Xu, C., Nie, Z., Wang, S., Zhu, Y., Liu, X., & Guo, Y. (2026). A Novel LMX1A Frameshift Variant Underlies Familial Phenotypic Heterogeneity in DFNA7. Human Mutation, 2026(1). https://doi.org/10.1155/humu/9930672
Vancouver
Xu C, Nie Z, Wang S, Zhu Y, Liu X, Guo Y. A Novel LMX1A Frameshift Variant Underlies Familial Phenotypic Heterogeneity in DFNA7. Human Mutation. 2026;2026(1). doi:10.1155/humu/9930672
BibTeX
@article{Xu2026,
author = {Xu, Chenyang and Nie, Zhipeng and Wang, Suyang and Zhu, Yiming and Liu, Xiaowen and Guo, Yufen},
title = {A Novel LMX1A Frameshift Variant Underlies Familial Phenotypic Heterogeneity in DFNA7},
journal = {Human Mutation},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/humu/9930672}
}
EUVIMED